195 related articles for article (PubMed ID: 12496042)
1. Point: myeloperoxidase -463G --> a polymorphism and lung cancer risk.
Feyler A; Voho A; Bouchardy C; Kuokkanen K; Dayer P; Hirvonen A; Benhamou S
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1550-4. PubMed ID: 12496042
[TBL] [Abstract][Full Text] [Related]
2. Myeloperoxidase -463G>A polymorphism and risk of primary lung cancer in a Korean population.
Park JH; Park JM; Kim EJ; Cha SI; Lee EB; Kim CH; Kam S; Jung TH; Park JY
Cancer Detect Prev; 2006; 30(3):257-61. PubMed ID: 16844322
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer.
Park JY; Lee SY; Jeon HS; Bae NC; Chae SC; Joo S; Kim CH; Park JH; Kam S; Kim IS; Jung TH
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):23-7. PubMed ID: 11815397
[TBL] [Abstract][Full Text] [Related]
4. Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer.
Jeon HS; Kim KM; Park SH; Lee SY; Choi JE; Lee GY; Kam S; Park RW; Kim IS; Kim CH; Jung TH; Park JY
Carcinogenesis; 2003 Oct; 24(10):1677-81. PubMed ID: 12869423
[TBL] [Abstract][Full Text] [Related]
5. Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk.
Schabath MB; Spitz MR; Delclos GL; Gunn GB; Whitehead LW; Wu X
Am J Ind Med; 2002 Jul; 42(1):29-37. PubMed ID: 12111688
[TBL] [Abstract][Full Text] [Related]
6. Myeloperoxidase: new polymorphisms and relation with lung cancer risk.
Chevrier I; Stücker I; Houllier AM; Cenée S; Beaune P; Laurent-Puig P; Loriot MA
Pharmacogenetics; 2003 Dec; 13(12):729-39. PubMed ID: 14646692
[TBL] [Abstract][Full Text] [Related]
7. Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant--463A of the myeloperoxidase gene.
Cascorbi I; Henning S; Brockmöller J; Gephart J; Meisel C; Müller JM; Loddenkemper R; Roots I
Cancer Res; 2000 Feb; 60(3):644-9. PubMed ID: 10676648
[TBL] [Abstract][Full Text] [Related]
8. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Bernges U; Philipp M; Woitowitz HJ
Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
[TBL] [Abstract][Full Text] [Related]
9. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung.
Larsen JE; Colosimo ML; Yang IA; Bowman R; Zimmerman PV; Fong KM
Carcinogenesis; 2006 Mar; 27(3):525-32. PubMed ID: 16195240
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants of myeloperoxidase and lung cancer risk.
Schabath MB; Spitz MR; Zhang X; Delclos GL; Wu X
Carcinogenesis; 2000 Jun; 21(6):1163-6. PubMed ID: 10837005
[TBL] [Abstract][Full Text] [Related]
11. Association between the risk for lung adenocarcinoma and a (-4) G-to-A polymorphism in the XPA gene.
Butkiewicz D; Popanda O; Risch A; Edler L; Dienemann H; Schulz V; Kayser K; Drings P; Bartsch H; Schmezer P
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2242-6. PubMed ID: 15598786
[TBL] [Abstract][Full Text] [Related]
12. hOGG1 Ser326Cys polymorphism and risk of lung cancer by histological type.
Okasaka T; Matsuo K; Suzuki T; Ito H; Hosono S; Kawase T; Watanabe M; Yatabe Y; Hida T; Mitsudomi T; Tanaka H; Yokoi K; Tajima K
J Hum Genet; 2009 Dec; 54(12):739-45. PubMed ID: 19881468
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer risk in nonsmokers and GSTM1 and GSTT1 genetic polymorphism.
Malats N; Camus-Radon AM; Nyberg F; Ahrens W; Constantinescu V; Mukeria A; Benhamou S; Batura-Gabryel H; Bruske-Hohlfeld I; Simonato L; Menezes A; Lea S; Lang M; Boffetta P
Cancer Epidemiol Biomarkers Prev; 2000 Aug; 9(8):827-33. PubMed ID: 10952100
[TBL] [Abstract][Full Text] [Related]
14. The MPO -463G>A polymorphism and cancer risk: a meta-analysis based on 43 case-control studies.
Chu H; Wang M; Wang M; Gu D; Wu D; Zhang Z; Tang J; Zhang Z
Mutagenesis; 2010 Jul; 25(4):389-95. PubMed ID: 20418356
[TBL] [Abstract][Full Text] [Related]
15. [Gene polymorphism of myeloperoxidase and genetic susceptibility to lung cancer].
Wu XM; Zhou YK; Ren S; Hao QL
Ai Zheng; 2003 Sep; 22(9):912-5. PubMed ID: 12969520
[TBL] [Abstract][Full Text] [Related]
16. Myeloperoxidase G-463A polymorphism and the risk of gastric cancer: a case-control study.
Zhu H; Yang L; Zhou B; Yu R; Tang N; Wang B
Carcinogenesis; 2006 Dec; 27(12):2491-6. PubMed ID: 16829688
[TBL] [Abstract][Full Text] [Related]
17. +61A>G polymorphism in the EGF gene does not increase the risk of lung cancer.
Kang HG; Choi JE; Lee WK; Kam S; Cha SI; Kim CH; Jung TH; Park JY
Respirology; 2007 Nov; 12(6):902-5. PubMed ID: 17986122
[TBL] [Abstract][Full Text] [Related]
18. O6-alkylguanine-DNA alkyltransferase gene polymorphisms and the risk of primary lung cancer.
Chae MH; Jang JS; Kang HG; Park JH; Park JM; Lee WK; Kam S; Lee EB; Son JW; Park JY
Mol Carcinog; 2006 Apr; 45(4):239-49. PubMed ID: 16385589
[TBL] [Abstract][Full Text] [Related]
19. The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer.
Zhou W; Thurston SW; Liu G; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):461-6. PubMed ID: 11352855
[TBL] [Abstract][Full Text] [Related]
20. Sequence variants of NAT1 and NAT2 and other xenometabolic genes and risk of lung and aerodigestive tract cancers in Central Europe.
McKay JD; Hashibe M; Hung RJ; Wakefield J; Gaborieau V; Szeszenia-Dabrowska N; Zaridze D; Lissowska J; Rudnai P; Fabianova E; Mates D; Foretova L; Janout V; Bencko V; Chabrier A; Hall J; Boffetta P; Canzian F; Brennan P
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):141-7. PubMed ID: 18199719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
